FDA Advisory Panel Recommends 6 Peptides for Compounding — But Scientists Objected
The FDA’s Pharmacy Compounding Advisory Committee (PCAC) voted on July 23–24, 2026 to recommend six peptides for inclusion on the 503A Compounding Bulk Substances List. It was the most significant regulatory event in the peptide research market in years —…
